1. Home
  2. BBGI vs CURX Comparison

BBGI vs CURX Comparison

Compare BBGI & CURX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beasley Broadcast Group Inc.

BBGI

Beasley Broadcast Group Inc.

N/A

Current Price

$26.50

Market Cap

10.5M

ML Signal

N/A

CURX

Curanex Pharmaceuticals Inc

HOLD

Current Price

$0.27

Market Cap

9.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBGI
CURX
Founded
1961
2018
Country
United States
United States
Employees
N/A
6
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.5M
9.4M
IPO Year
1999
2025

Fundamental Metrics

Financial Performance
Metric
BBGI
CURX
Price
$26.50
$0.27
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
32.1K
61.7K
Earning Date
04-08-2026
09-09-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.77
N/A
Revenue
$232,179,463.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.48
N/A
Revenue Growth
69.89
N/A
52 Week Low
$3.14
$0.26
52 Week High
$26.37
$9.18

Technical Indicators

Market Signals
Indicator
BBGI
CURX
Relative Strength Index (RSI) 65.57 38.14
Support Level $3.93 $0.26
Resistance Level N/A $0.40
Average True Range (ATR) 2.61 0.03
MACD 0.30 -0.00
Stochastic Oscillator 89.41 13.23

Price Performance

Historical Comparison
BBGI
CURX

About BBGI Beasley Broadcast Group Inc.

Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The company operates in two segments Audio and Digital.

About CURX Curanex Pharmaceuticals Inc

Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.

Share on Social Networks: